193 related articles for article (PubMed ID: 17000025)
21. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
[TBL] [Abstract][Full Text] [Related]
22. Ultrastructural findings in epidermolysis bullosa.
Smith LT
Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
[TBL] [Abstract][Full Text] [Related]
23. Laminin-5 inhibits human keratinocyte migration.
O'Toole EA; Marinkovich MP; Hoeffler WK; Furthmayr H; Woodley DT
Exp Cell Res; 1997 Jun; 233(2):330-9. PubMed ID: 9194495
[TBL] [Abstract][Full Text] [Related]
24. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells.
Ryan MC; Lee K; Miyashita Y; Carter WG
J Cell Biol; 1999 Jun; 145(6):1309-23. PubMed ID: 10366601
[TBL] [Abstract][Full Text] [Related]
25. Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa.
McMillan JR; McGrath JA; Tidman MJ; Eady RA
J Invest Dermatol; 1998 Feb; 110(2):132-7. PubMed ID: 9457907
[TBL] [Abstract][Full Text] [Related]
26. Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.
Mühle C; Jiang QJ; Charlesworth A; Bruckner-Tuderman L; Meneguzzi G; Schneider H
Hum Genet; 2005 Jan; 116(1-2):33-42. PubMed ID: 15538630
[TBL] [Abstract][Full Text] [Related]
27. Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders.
Varkey M; Ding J; Tredget EE
Tissue Eng Part A; 2014 Feb; 20(3-4):540-52. PubMed ID: 24004160
[TBL] [Abstract][Full Text] [Related]
28. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
Meneguzzi G; Marinkovich MP; Aberdam D; Pisani A; Burgeson R; Ortonne JP
Exp Dermatol; 1992 Dec; 1(5):221-9. PubMed ID: 1365323
[TBL] [Abstract][Full Text] [Related]
29. The importance of laminin 5 in the dermal-epidermal basement membrane.
Nishiyama T; Amano S; Tsunenaga M; Kadoya K; Takeda A; Adachi E; Burgeson RE
J Dermatol Sci; 2000 Dec; 24 Suppl 1():S51-9. PubMed ID: 11137397
[TBL] [Abstract][Full Text] [Related]
30. Molecular complexity of the cutaneous basement membrane zone.
Uitto J; Pulkkinen L
Mol Biol Rep; 1996; 23(1):35-46. PubMed ID: 8983017
[TBL] [Abstract][Full Text] [Related]
31. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
32. alpha3beta1 and alpha6beta4 integrin receptors for laminin-5 are not essential for epidermal morphogenesis and homeostasis during skin development.
DiPersio CM; van der Neut R; Georges-Labouesse E; Kreidberg JA; Sonnenberg A; Hynes RO
J Cell Sci; 2000 Sep; 113 ( Pt 17)():3051-62. PubMed ID: 10934043
[TBL] [Abstract][Full Text] [Related]
33. Amino acid substitution in the C-terminal domain of collagen XVII reduces laminin-332 interaction causing mild skin fragility with atrophic scarring.
Kroeger J; Hoppe E; Galiger C; Has C; Franzke CW
Matrix Biol; 2019 Jul; 80():72-84. PubMed ID: 30316981
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J
Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
36. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
[TBL] [Abstract][Full Text] [Related]
37. Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literature.
Bauer J; Schumann H; Sönnichsen K; Tomaske M; Bosk A; Bruckner-Tuderman L; Rassner G; Garbe C
Eur J Pediatr; 2002 Dec; 161(12):672-9. PubMed ID: 12447669
[TBL] [Abstract][Full Text] [Related]
38. Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family.
Badran EF; Battah HA; Akl KF; Khalil RW; Al Amori I
Australas J Dermatol; 2013 Aug; 54(3):218-21. PubMed ID: 22963541
[TBL] [Abstract][Full Text] [Related]
39. Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.
Spirito F; Charlesworth A; Linder K; Ortonne JP; Baird J; Meneguzzi G
J Invest Dermatol; 2002 Sep; 119(3):684-91. PubMed ID: 12230513
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition.
Castiglia D; Posteraro P; Spirito F; Pinola M; Angelo C; Puddu P; Meneguzzi G; Zambruno G
J Invest Dermatol; 2001 Sep; 117(3):731-9. PubMed ID: 11564184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
